Refine Search
(4)
(8)
(8)
(8)

Dermatology

Currently, skin conditions are ranked as the 18th leading cause of global disability-adjusted life years (DALYs), which refer to the years lived with disability. Approximately one-fourth of the US population i.e. 84.5 million was affected by skin disease in 2013 (Source: American Academy of Dermatology). Across the 7MM, the population suffering from acne vulgaris and atopic dermatitis stood at 128.9 million and 34.5 million, respectively, in 2017.

Chronic Urticaria Or Hives - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Urticaria Or Hives - Pipeline Review, H1 2018’, provides an overview of the Chronic Urticaria Or Hives pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Acne Vulgaris - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H1 2018’, provides an overview of the Acne Vulgaris pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acne Vulgaris, com...

Axillary Hyperhidrosis - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Axillary Hyperhidrosis - Pipeline Review, H1 2018’, provides an overview of the Axillary Hyperhidrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Psoriasis - Pipeline Review, H1 2018

  • $2,500
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2018’, provides an overview of the Psoriasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with a...

Atopic Dermatitis - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H1 2018’, provides an overview of the Atopic Dermatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Atopic Der...

Scar - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Scar - Pipeline Review, H1 2018’, provides an overview of the Scar pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Scar, complete with analysis by stag...

Burns - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burns - Pipeline Review, H1 2018’, provides an overview of the Burns pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Burns, complete with analysis by s...

Wounds - Pipeline Review, H2 2017

  • $2,000
  • December 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Wounds - Pipeline Review, H2 2017’, provides an overview of the Wounds pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Wounds, complete with analysis b...